التفاصيل البيبلوغرافية
| العنوان: |
Guidelines for the treatment and management of new-onset diabetes after transplantation. |
| المؤلفون: |
Wilkinson, Alan, Davidson, Jaime, Dotta, Francesco, Home, Philip D., Keown, Paul, Kiberd, Bryce, Jardine, Alan, Levitt, Naomi, Marchetti, Piero, Markell, Mariana, Naicker, Sarala, O'Connell, Philip, Schnitzler, Mark, Standl, Eberhard, Torregosa, Jose-Vicente, Uchida, Kazuharu, Valantine, Hannah, Villamil, Federico, Vincenti, Flavio, Wissing, Martin |
| المصدر: |
Clinical Transplantation; Jun2005, Vol. 19 Issue 3, p291-298, 8p, 2 Diagrams, 2 Charts |
| مصطلحات موضوعية: |
DIABETES, KIDNEY transplantation, LIVER transplantation, HEART transplantation, TRANSPLANTATION of organs, tissues, etc. |
| مستخلص: |
Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa J-V, Uchida K, Valantine H, Villamil F, Vincenti F, Wissing M. Guidelines for the treatment and management of new-onset diabetes after transplantation.Clin Transplant 2005 DOI: 10.1111/j.1399-0012.2005.00359.x© Blackwell Munksgaard, 2005Although graft and patient survival after solid organ transplantation have improved markedly in recent years, transplant recipients continue to experience an increased prevalence of cardiovascular disease (CVD) compared with the general population. A number of factors are known to impact on the increased risk of CVD in this population, including hypertension, dyslipidemia and diabetes mellitus. Of these factors, new-onset diabetes after transplantation has been identified as one of the most important, being associated with reduced graft function and patient survival, and increased risk of graft loss. In 2003, International Consensus Guidelines on New-onset Diabetes after Transplantation were published, which aimed to establish a precise definition and diagnosis of the condition and recommend management strategies to reduce its occurrence and impact. These updated 2004 guidelines, developed in consultation with the International Diabetes Federation (IDF), extend the recommendations of the previous guidelines and encompass new-onset diabetes after kidney, liver and heart transplantation. It is hoped that adoption of these management approaches pre- and post-transplant will reduce individuals’ risk of developing new-onset diabetes after transplantation as well as ameliorating the long-term impact of this serious complication. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Transplantation is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
